Cbot — Merger or Acquisition (June 2007)
20 slides from Cbot's merger presentation, Jun 5, 2007
Slide 1: CBOT/CME: A Combination to Compete Successfully in the Global Marketplace
Filed by CBOT Holdings, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934 Subject Company CBOT Holdings, Inc. (Commission File No. 001-32650) CBOT/CME: A Combination to Compete Successfully in the Global Marke
Slide 2: Forward Looking Statements
Forward Looking Statements JUNE 2007 Certain statements in this presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and includes any use of the words “may,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “e
Slide 3: Discussion Overview
Discussion Overview Transaction Summary CME/CBOT Strategic Fit Exercise Rights and Member Rights Break Up Fee Stock Valuation Risks Associated with ICE Proposal Summary
Slide 4: Transaction Summary
Transaction Summary For each CBOT share, shareholders will receive 0.3500 CME shares Consideration: All stock transaction; cash election eliminated CME Shareholders: 65.4% Pro Forma Ownership: CBOT Shareholders: 34.6% Accretive to earnings of the combined company on a cash basis within 12 Expected A
Slide 5: CME/CBOT: A Strategic Fit
CME/CBOT: A Strategic Fit Creates world’s largest futures exchange Clearly aligned with CBOT’s strategic vision Better positioned to pursue immediate and long term growth opportunities Entails low integration and execution risk Better able to compete and win in changing global marketplace
Slide 6: Clearly Aligned with CBOT Strategic Vision
Clearly Aligned with CBOT Strategic Vision Expands access to global markets Offers innovative new trading opportunities Enhances depth and breadth of liquidity that we provide the market place Provides long term value to stockholders and members
Slide 7: Better Positioned for Immediate and Long-Term Growth Opportunities
Better Positioned for Immediate and Long-Term Growth Opportunities Can immediately pursue OTC growth opportunities Greater diversity of revenues Complementary products create opportunities for significant revenue/growth synergies Financials, equities and agricultural products Both organizations have
Slide 8: Entails Low Integration and Execution Risk
Entails Low Integration and Execution Risk Builds on strong productive relationship between CME and CBOT over many years CME and CBOT have proven track record in integration Successful integration of CCL in 9 months CME integration of NYMEX in 2 months Speed to integration Migration to Globex expect
Slide 9: Substantial Synergy Potential: Realizable & Certain
Substantial Synergy Potential: Realizable & Certain Cost synergies of $150 million already identified Includes technology, trading floor consolidation and administrative Expected to be accretive to earnings on a cash basis within 12 months and on GAAP basis within 12-18 months Share repurchase expec
Slide 10: Opportunities for Significant Revenue Synergies
Opportunities for Significant Revenue Synergies Large Scalable Platforms • Trade matching • Clearing processing Product Innovation Broadest Global Presence • Yield curve products • Immediate customer base • Spread products/functionalities growth in 80+ countries • Strong entry point for credit, • Im
Slide 11: Improved Competitiveness in Global Marketplace
Improved Competitiveness in Global Marketplace Combined organization will be better positioned to compete globally Environment is changing rapidly with increased consolidation and this combination allows us to succeed on global basis Can pursue untapped global growth Customers in more than 80 countr
Slide 12: Positioned for Global Growth
Positioned for Global Growth CBOT/CME will pursue relatively untapped global growth strengthened by: A broad product offering that has wide global appeal Expansive distribution with international hubs and global customers CBOT/CME customers in more than 80 countries 7 European/Asian hubs
Slide 13: Member Rights Better Protected Under CME Agreement
Member Rights Better Protected Under CME Agreement CBOT designates individuals to serve as CBOT directors on combined company’s board For two years after closing, rule changes that would impair business opportunities of CBOT members would need approval by committee that includes majority of CBOT dir
Slide 14: Exercise Rights
Exercise Rights Exercise right holders represented as a class by separate counsel in Delaware litigation Unclear what basis ICE, CBOE or even CBOT would have to settle their claims In Delaware litigation we are seeking equal treatment of CBOT Eligible Full Members in CBOE’s demutualization The CME a
Slide 15: Exercise Rights
Exercise Rights Our position that the conditions of the 1992 Agreement are satisfied in connection with the CME merger is well founded The surviving entity is an exchange (CBOT will continue to exist as an exchange after the merger) CBOT full members will be granted membership in the surviving entit
Slide 16: Break Up Fee
Break Up Fee Break up fees are standard in large transactions CBOT members and shareholders likely would ultimately NOT pay break up fee We would seek to have any alternative bidder pay break up fee This is not a one-way street: if CME backs out of the deal, CBOT would get break up fee Break up fee
Slide 17: Combination with ICE Presents Significant Risks
Combination with ICE Presents Significant Risks Risks related to integration and execution and, thus, to the long-term value of combined company Functionality and scale of ICE’s clearing and electronic platform would need to be significantly increased to support CBOT customers and trading volume Mig
Slide 18: Combination with ICE Presents Significant Risks
Combination with ICE Presents Significant Risks Integration would be overseen and managed by a board comprised of a majority of ICE directors and ICE management Product development may be adversely affected during migration to ICE platform Loss of critical personnel during migration creates addition
Slide 19: Agreement with CME Allows Us to Win Globally
Agreement with CME Allows Us to Win Globally The CME/CBOT merger creates the world’s largest futures exchange and significant long-term value for CBOT Holdings’ stockholders, members and customers A merged CME/CBOT will be better able to compete globally in a rapidly changing industry Working togeth
Slide 20: Exchange ADV
Exchange ADV Average Daily Volume by Exchange (in thousands) Note: ADV and Volume information from company websites CME NYMEX CBOT ICE Futures NYBOT 7,000 6,454 6,000 5,367 5,512 5,313 5,000 4,000 3,000 2,000 3,866 1,512 3,574 1,324 3,163 3,269 1,398 1,200 1,000 548 426 448 506 169 161 207 214 0 3Q0